about
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeHomovanilic acid in Huntington's disease and Sydenham's choreaTelmisartan to prevent recurrent stroke and cardiovascular events.Different locations but common associations in subcortical hypodensities of presumed vascular origin: cross-sectional study on clinical and neurosonologic correlates.Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis.Mitochondrial DNA variants in a portuguese population of patients with Alzheimer's disease.Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.Frontotemporal dementia and mitochondrial DNA transitions.Nocturnal blood pressure dipping in acute ischemic stroke.Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.Dominantly inherited ataxias in Portugal.Glutamate Dehydrogenase Deficiency in Machado-Joseph Disease[2 cases of stiff-man syndrome with tremor][Hemato-ocular barriers in multiple sclerosis. Angiographic and fluorometric study]Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working GroupDownbeat nystagmus elicited by eyelid closure
P50
Q24645205-A4CCFBBA-3861-4229-80E5-17F8E66778D9Q24646522-993D83B7-53E9-45C7-8ABB-F19EDDF4A60FQ28366710-10EA549C-8422-4C3C-AC5F-C441C1F09523Q34596294-2AC28874-6FFF-46E5-8A1C-0BCF7D768DFDQ37568179-970AF8A7-9601-41F6-AACF-F2DEA7086B12Q39315140-92CD2431-82DD-48F5-92A1-3608FD3D16EFQ47365588-D1C2BF58-7AC9-40ED-B59C-1424BF67FE1FQ47805998-1C4028B5-0634-4C77-B1ED-72D342AA26AFQ47873488-68DEDBFB-0917-4F4B-860B-3CD183BAEB75Q47986294-75401DA6-63B8-4EE2-B518-A355CC2829C0Q48262809-6A6F618F-8574-4BC7-BC66-1BAB6AA67839Q48296597-095DFF38-7251-4040-A7D0-DBD8D356275CQ52808173-9BDDEED0-EAF6-46F9-AC0B-78C7F220C96DQ63208593-EDE39E94-A3A6-436C-9DD6-CE708D9FEC06Q70172552-FDCB3340-CD9D-4DEC-B4EC-8045262DAB9BQ71215619-73590616-9446-41C1-8552-84A91AD140C5Q72996478-07B224D5-8957-41DC-87AD-C6C168CBF4DDQ87517324-AED1A78E-A56B-44AF-BAF2-F29B9AD9FF45
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-0828-3485
@en
name
Luis Cunha
@ast
Luis Cunha
@en
Luis Cunha
@es
Luis Cunha
@nl
Luis Cunha
@sl
type
label
Luis Cunha
@ast
Luis Cunha
@en
Luis Cunha
@es
Luis Cunha
@nl
Luis Cunha
@sl
prefLabel
Luis Cunha
@ast
Luis Cunha
@en
Luis Cunha
@es
Luis Cunha
@nl
Luis Cunha
@sl
P106
P21
P31
P496
0000-0002-0828-3485